New Clinical Trial Shows Promise for Combining Hypofractionated Radiotherapy with Immunotherapy in Advanced Cancer
A new multicenter Phase II clinical trial, led by researchers from several institutions including Jiangsu Cancer Hospital, is showing promising results in treating patients with advanced metastatic solid tumors. This…